Endocrine Society Journals Earn Higher 2020 Impact Factors

  • Jun 2021
endocrine reviews dec 2020

Endocrine Society Journals experienced large Impact Factor increases, led by Endocrine Reviews, according to Clarivate’s recently released annual Journal Citation Report (JCR) for 2020. 

A highly regarded metric used to measure the success of scholarly journals, the 2020 Impact Factor is calculated by tracking how many times articles that a journal published in 2018 and 2019 were cited by authors during 2020. The number of citations is then divided by the total number of citable articles published in that journal in 2018 and 2019 to arrive at the Impact Factor. 

“I’m delighted that our journals’ scores improved so much since the last Impact Factor report,” says Daniel Spratt, MD, chair of the Endocrine Society’s Publications Core Committee. “The recognition is well deserved and a result of all the hard work of our authors, reviewers, and editors to publish the most innovative research in the field.” 

Endocrine Reviews saw the biggest increase in Impact Factor among the Society’s journals, rising from 14.661 in 2019 to 19.871 in 2020, and is ranked fourth out of more than 175 journals in the Endocrinology and Metabolism JCR category. The journal publishes bimonthly comprehensive, authoritative, and timely review articles balancing both experimental and clinical endocrinology themes. 

The Journal of Clinical Endocrinology and Metabolism’s (JCEM) Impact Factor increased from 5.399 in 2019 to 5.958 in 2020 and continues to be the most cited journal in Endocrinology and Metabolism. JCEM is the world’s leading peer-reviewed journal for endocrine clinical research and clinical practice. 

Endocrinology, the Endocrine Society’s flagship basic science journal, saw its Impact Factor increased from 3.934 to 4.736, and has the highest cited half-life in Endocrinology and Metabolism.  

The Society’s newest journal, the open access Journal of the Endocrine Society, launched in 2017, is listed in indexes including Scopus and Clarivate’s Emerging Sources Citation Index, and is a candidate to receive its first Impact Factor next year. 

You may also like

  • Endocrine Society Endorses Bipartisan Bill to Address Insulin Affordability 

    INSULIN Act would expand insulin co-pay cap to commercial market and encourage competition. The Endocrine Society today endorsed the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act, a bipartisan bill to address insulin affordability introduced by Sens. Jeanne Shaheen (D-NH), Susan Collins (R-ME), Raphael Warnock (D-GA), and John Kennedy (R-LA).   This historic legislation would cap out-of-pocket insulin costs at $35 per month for people on private insurance, protecting access to this life-saving medication for millions of people with diabetes. The legislation also would create a program to…

  • In Memoriam: Martin Savage 1941-2026

    By Richard Ross, Emeritus Professor of Endocrinology, University of Sheffield, UK, and Helen Storr, Professor of Pediatric Endocrinology, Queen Mary University London

    Martin O. Savage, Emeritus Professor of Pediatric Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, passed away on February 24, 2026. Martin Savage was a kind, generous, quietly spoken man, an inspirational pediatrician and an internationally renowned clinician scientist. He was passionate about teaching…

Find more in